Abstract |
5-Hydroxytryptophan (5-HTP) is a drug that is clinically effective against depression, insomnia, obesity, chronic headaches, etc. It is only commercially produced by the extraction from the seeds of Griffonia simplicifolia because of a lack of synthetic methods. Here, we report the efficient microbial production of 5-HTP via combinatorial protein and metabolic engineering approaches. First, we reconstituted and screened prokaryotic phenylalanine 4-hydroxylase activity in Escherichia coli. Then, sequence- and structure-based protein engineering dramatically shifted its substrate preference, allowing for efficient conversion of tryptophan to 5-HTP. Importantly, E. coli endogenous tetrahydromonapterin (MH4) could be utilized as the coenzyme, when a foreign MH4 recycling mechanism was introduced. Whole-cell bioconversion allowed the high-level production of 5-HTP (1.1-1.2 g/L) from tryptophan in shake flasks. On this basis, metabolic engineering efforts were further made to achieve the de novo 5-HTP biosynthesis from glucose. This work not only holds great scale-up potential but also demonstrates a strategy for expanding the native metabolism of microorganisms.
|
Authors | Yuheng Lin, Xinxiao Sun, Qipeng Yuan, Yajun Yan |
Journal | ACS synthetic biology
(ACS Synth Biol)
Vol. 3
Issue 7
Pg. 497-505
(Jul 18 2014)
ISSN: 2161-5063 [Electronic] United States |
PMID | 24936877
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Neurotransmitter Agents
- Recombinant Proteins
- Tryptophan
- 5-Hydroxytryptophan
- Phenylalanine Hydroxylase
|
Topics |
- 5-Hydroxytryptophan
(biosynthesis, chemistry)
- Escherichia coli
(genetics, metabolism)
- Humans
- Metabolic Engineering
- Neurotransmitter Agents
(biosynthesis, chemistry)
- Phenylalanine Hydroxylase
(genetics, metabolism)
- Phylogeny
- Protein Engineering
- Pseudomonas
(enzymology)
- Recombinant Proteins
(genetics, metabolism)
- Tryptophan
(chemistry, metabolism)
|